Delta-Fly Pharma, Inc. (TYO:4598)

Delta-Fly Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	1,763	2,371	5,595	6,929	6,560	6,937
Market Cap Growth	-61.61%	-57.62%	-19.26%	5.62%	-5.43%	-5.49%
Enterprise Value	1,618	2,131	4,857	5,202	5,763	5,596
Last Close Price	145.00	195.00	575.00	842.00	1030.00	1280.00
PS Ratio	-	-	-	-	-	23.12
PB Ratio	53.43	71.85	20.27	5.63	8.30	5.63
P/TBV Ratio	53.43	71.85	20.27	5.63	8.30	5.63
EV/Sales Ratio	-	-	-	-	-	18.65
Net Debt / Equity Ratio	-4.39	-4.39	-1.23	-1.15	-1.07	-1.03
Net Debt / EBITDA Ratio	0.09	0.09	0.20	1.01	0.64	1.32
Net Debt / FCF Ratio	0.09	0.09	0.18	1.11	0.65	1.35
Asset Turnover	-	-	-	-	-	0.17
Quick Ratio	0.95	0.95	2.49	5.88	7.34	13.93
Current Ratio	0.98	0.98	2.53	5.94	7.53	14.07
Return on Equity (ROE)	-1051.78%	-1051.78%	-228.40%	-141.41%	-131.35%	-58.43%
Return on Assets (ROA)	-295.04%	-295.04%	-111.90%	-73.69%	-73.71%	-34.47%
Return on Capital Employed (ROCE)	-4720.60%	-4720.60%	-614.40%	-113.80%	-166.20%	-77.90%
Earnings Yield	-92.16%	-68.53%	-30.76%	-20.62%	-20.24%	-13.94%
FCF Yield	-	-65.66%	-32.78%	-18.47%	-19.86%	-13.55%
Buyback Yield / Dilution	-31.55%	-31.55%	-22.38%	-26.91%	-4.61%	-17.64%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error